AdvertisementAdvertise with NZME.
Stock Takes
Stock Takes: Why NZ's largest firms are suddenly ripe for takeover talks
Fletcher Building, Spark and Ryman are potentially all on the radar.
Stock Takes: Why more Kiwis are taking a punt on Wall St
Plus: Auckland Airport and Spark are back in favour with analysts at Morningstar.
Spark auctioning half its data centre business to fund $1b expansion push: report
Surf's up for the telco as its capital-raising effort comes to the sharp end.
Tech Insider: Blackbird partner says Govt made mistake giving up on $300m Elevate fund
PLUS: Blackbird gears up for $1 billion raise.
Stock Takes: NZ shares are down, but not out
New Zealand's sharemarket is in correction mode, but is faring better than others.
Stock Takes: Who’s lining up to buy Fonterra’s Mainland and how much is it worth?
Fonterra's Mainland sale process continues despite a turbulent sharemarket.
Stock Takes: Has ethical investing lost its shine?
The change of Government in the United States has put ESG investing on the back foot.
Stock Takes: Is gold a good bet?
Gold has hit a record high this week but is it a good investment?
Stock Takes: Focus turns to second half after RBNZ rate cut
Focus has turned to those companies who will benefit from this week's RBNZ rate cut.
Stock Takes: Air NZ banks on loyal fliers for revenue boost
Analysts upgrade airline's rating but are dubious about some of its revenue plans.
Stock Takes: The big issues facing F&P Healthcare
F&P Healthcare's share price has held despite concerns about the US health sector.
Stock Takes: Why a2 is out of favour, and a role reversal for Fonterra
Private equity is seen as a likely buyer for Fonterra's consumer business.
'Money for jam': How much bankers made from Auckland Airport’s whopper capital raise
Plus: Sky TV gets a thumbs-up for its deal-making skills.
Stock Takes: A capital raise for Infratil? Comvita’s mystery bidder
How will Infratil fund its ambitious plans for its Aussie data centre business?
Stock Takes: F&P Healthcare rebounds, tech sector surges and what next for cannabis company?
F&P Healthcare recovers after a sell-off, and what's in store now for Cannasouth.
Stock Takes: Life in the fast lane - the auto stocks bucking NZ’s downtrend
And will new car dealership Armstrong’s try listing on the sharemarket again?
Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.
Stock Takes: NZ Shareholders Association on seeing the wood for the trees
The NZSA has questioned the timeliness of PGW's disclosure.
Is this tech company the next Xero?
This freshly listed tech start-up is back by Sir Owen Glenn.